Quanterix to report first-quarter 2026 financial results on May 6
Quanterix said it will host a conference call on May 6, 2026, at 4:30 p.m. E.T. to discuss first-quarter 2026 financial results. A press release will be issued after the market closes the same day.
Quanterix Corporation said it will host a conference call on Wednesday, May 6, 2026, at 4:30 p.m. E.T., to discuss its first quarter 2026 financial results. The company will issue a press release regarding its first quarter 2026 financial results prior to the conference call on Wednesday, May 6, 2026, after the market closes. The press release will be posted on the Quanterix website.
Interested investors can listen to the live webcast from the Event Details page in the Investors section of the Quanterix website. An archived webcast replay will be available on the company’s website for one year.
Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits.
With approximately 6,300 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,439 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics.